Prostate News Archive
18-Jul-2007
Protox Announces Positive Clinical Data From Prostate Cancer Study (T-Net British Columbia)
Vancouver, BC, July 16, 2007--(T-Net)--Protox Therapeutics Inc. (TSX-V:PRX) today announced positive top-line results from its Phase 1 clinical trial evaluating PRX302 in patients with localized, recurrent prostate cancer following radiation failure. Comstock dies after 12-year battle with prostate cancer (The Herald-Mail)
Smithsburg resident Dr. George W. Comstock, who dedicated his life to public health, died Sunday afternoon at his home after a 12-year battle with prostate cancer. George W. Comstock, 92; epidemiologist was influential in the treatment of tuberculosis (Los Angeles Times)
Dr. George W. Comstock, a pioneering epidemiologist who almost single-handedly blocked the use of the flawed BCG tuberculosis vaccine in the United States and who played a key role in the development of other prevention strategies against the disease, died Sunday at his home in Smithsburg, Md. He was 92 and had battled prostate cancer for several years. Improved Prediction of Prostate Cancer Recurrence Through Systems Pathology (Business Wire via Yahoo! Finance)
YONKERS, N.Y.----Aureon Laboratories and their collaborators announced today the publication of their 'Systems Pathology' model for predicting prostate cancer PSA recurrence in the Journal of Clinical Investigation .
Back to Prostate News Archive
